High incidence of neutropenia in patients treated with rituximab after autologous stem cell transplantation

Haematologica. 2004 Mar;89(3):361-3.

Abstract

We report a high incidence of neutropenia in patients treated with rituximab prior to and following autologous stem cell transplantation (ASCT). Fourteen patients with follicular or mantle-cell lymphoma were treated with high dose (HD) therapy followed by an in vivo-purged autologous graft.

Publication types

  • Letter

MeSH terms

  • Adult
  • Antibodies, Monoclonal / adverse effects*
  • Antibodies, Monoclonal, Murine-Derived
  • Antineoplastic Combined Chemotherapy Protocols / adverse effects*
  • Bone Marrow Purging / adverse effects
  • Female
  • Humans
  • Lymphoma, Follicular / therapy
  • Lymphoma, Mantle-Cell / therapy
  • Male
  • Middle Aged
  • Neutropenia / etiology*
  • Peripheral Blood Stem Cell Transplantation / adverse effects*
  • Rituximab
  • Transplantation, Autologous

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Murine-Derived
  • Rituximab